$ITRM I am not a bear, but we all have to tread lightly. Truth is: No one knows what's going to happen. I can see it going either way--delay or approval. However, my thinking is if no update tomorrow, no news is not going to be good news. I still have a core position, but definitely reduced my exposure. I believe Sulopenem has great potential, but as with any biotech play, nothing is certain. Odssare not in our favor.
2
4
4 Likes